Neovalen (Benzylpenicillin)

Benzylpenicillin, the active ingredient in Neovalen, is a beta‑lactam antibiotic presented as an injectable solution for intramuscular and intravenous use. It treats a range of bacterial infections caused by susceptible Gram‑positive and some Gram‑negative organisms, and is administered under medical supervision.

GNH USA supplies Neovalen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Benzylpenicillin is used to treat infections caused by susceptible bacteria, primarily targeting the Gram‑positive and some Gram‑negative organisms.

- Streptococcal infections: eradicates Streptococcus species causing pharyngitis, scarlet fever, and cellulitis. - Penicillin‑sensitive staphylococcal infections: treats skin and soft‑tissue infections caused by susceptible Staphylococcus aureus. - Pneumococcal infections: effective against Streptococcus pneumoniae in pneumonia and meningitis. - Early syphilis: eliminates Treponema pallidum in primary and secondary stages. - Meningococcal infections: used for Neisseria meningitidis meningitis.

Adverse reactions to benzylpenicillin can vary from mild to severe and should be monitored during therapy.

Common Side Effects: - Injection site pain: local discomfort or erythema at the site of administration. - Diarrhea: mild gastrointestinal upset occurring during treatment. - Nausea: transient feeling of queasiness. - Rash: non‑specific skin eruption. - Fever: low‑grade temperature rise. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Anaphylaxis: rapid, life‑threatening allergic reaction requiring immediate medical attention. - Severe allergic reactions: including angioedema and bronchospasm. - Clostridioides difficile‑associated diarrhea: colitis caused by disruption of normal gut flora. - Serum sickness‑like reaction: fever, arthralgia, and rash occurring days after exposure. - Hemolytic anemia: immune‑mediated destruction of red blood cells. - Nephritis: inflammation of the kidneys presenting with hematuria or proteinuria.

Before initiating benzylpenicillin therapy, clinicians should consider several safety measures.

- Allergy assessment: avoid in patients with known penicillin hypersensitivity. - Renal function: adjust dosage in severe renal impairment to prevent accumulation. - Pregnancy: use only if clearly needed after risk‑benefit assessment. - Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents that may antagonize its effect. - Monitoring: observe for signs of hypersensitivity during the first administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Benzylpenicillin may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Methotrexate: increased toxicity and bone‑marrow suppression. - Oral contraceptives: reduced hormonal efficacy, risk of unintended pregnancy. - Probenecid: decreases renal excretion, raising penicillin levels. - Bacteriostatic antibiotics (e.g., tetracyclines, chloramphenicol): antagonistic effect on bacterial killing.

Moderate Interactions (Monitor Closely): - Aminoglycosides: monitor renal function due to additive nephrotoxicity. - Warfarin: may enhance anticoagulant effect; check INR regularly.